@lewybodysociety.bsky.social #LewyBodyAwarenessWeek From #AAIC2023

Preclinical Research on CRISPR-Based Gene Editing for Alzheimer Disease Treatment: Brent D. Aulston, PhD The postdoctoral fellow at the University of California San Diego discussed using CRISPR-based gene editing to alter the amyloid precursor protein gene in mice models with symptoms of Alzheimer disease. [WATCH TIME: 5 minutes]

Exciting news at #AAIC2023! CRISPR-based gene therapy shows promise in mice, tackling both familial and sporadic Alzheimer's disease, paving way for universal applicability. The therapy targets specific gene sequences relevant to AD for precise targeting.

neurologylive.com/view/preclinic…

Done.
#AAIC2023